Biweekly dose-dense gemcitabine-oxaliplatin and dexamethasone for relapsed/refractory aggressive non-Hodgkin lymphoma: A multicenter, single-arm, phase II trial-Reference-Cited by-同舟云学术

Biweekly dose-dense gemcitabine-oxaliplatin and dexamethasone for relapsed/refractory aggressive non-Hodgkin lymphoma: A multicenter, single-arm, phase II trial

Published:2016-03-09 Issue:2 Volume:12 Page:159-166
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clin Oncol

Author:

Jo Jae-Cheol¹,Baek Jin Ho¹,Lee Je-Hwan²,Joo Young-Don³,Bae Sung-Hwa⁴,Lee Jung-Lim⁵,Lee Jung-Hee²,Kim Dae-Young²,Lee Won-Sik⁶,Ryoo Hun Mo⁴,Choi Yunsuk¹,Kim Hawk¹,Lee Kyoo-Hyung²,

Affiliation:

1. Department of Hematology and Oncology, Ulsan University Hospital; University of Ulsan College of Medicine; Ulsan Korea

2. Department of Hematology; Asan Medical Center; University of Ulsan College of Medicine; Seoul Korea

3. Department of Hematology and Oncology; Haeundae Paik Hospital; Inje University College of Medicine; Busan Korea

4. Department of Hematology and Oncology; Daegu Catholic University Hospital; Daegu Korea

5. Department of Hematology and Oncology; Daegu Fatima Hospital; Daegu Korea

6. Department of Hematology and Oncology; Busan Paik Hospital; Inje University College of Medicine; Busan Korea

Funder

Ministry of Education, Science and Technology

Publisher

Wiley

Subject

Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12462/fullpdf

Reference37 articles.

1. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma;Fisher;N Engl J Med,1993

2. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP);Velasquez;Blood,1988

3. ESHAP-An effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study;Velasquez;J Clin Oncol,1994

4. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma;Philip;N Engl J Med,1995

5. Gemcitabine: preclinical pharmacology and mechanisms of action;Plunkett;Sem Oncol,1996

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gemcitabine, oxaliplatin and dexamethasone (GemDOx) as salvage therapy for relapsed or refractory diffuse large B-cell lymphoma and peripheral T-cell lymphoma;Journal of Cancer;2021